Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients

Published:2021-10-01 Issue:39 Volume:100 Page:e27374
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Li Zhengtian,Du Gang,Zhao Rong,Yang Wenkang,Li Chan,Huang Jun,Wen Zhenpei,Li Hening,Zhang Bo

Funder

the natural science foundation of guangxi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference52 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J Clin,2020

2. International variations and trends in renal cell carcinoma incidence and mortality;Znaor;Eur Urol,2015

3. Blood pressure and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition;Weikert;Am J Epidemiol,2008

4. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies;Renehan;Lancet (London, England),2008

5. Renal cell carcinoma;Jonasch;BMJ,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HDAC8 Enhances the Function of HIF‐2α by Deacetylating ETS1 to Decrease the Sensitivity of TKIs in ccRCC;Advanced Science;2024-07-29

2. ANKZF1 knockdown inhibits glioblastoma progression by promoting intramitochondrial protein aggregation through mitoRQC;Cancer Letters;2024-06

3. Bridging the gap between clear cell renal cell carcinoma and cutaneous melanoma: the role of SCARB1 in dysregulated cholesterol metabolism;Aging;2023-10-05

4. HIGD1A inactivated by DNA hypermethylation promotes invasion of kidney renal clear cell carcinoma;Pathology - Research and Practice;2023-05

5. In Vitro and In Silico Analysis of Epithelial-Mesenchymal Transition and Cancer Stemness as Prognostic Markers of Clear Cell Renal Cell Carcinoma;Cancers;2023-05-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3